Copart
CPRT Nasdaq· Diversified Support Services
Last close · Oct 26, 2026
$29.15
KIRA · Stoqly’s AI analyst, in plain words
- Copart had $4.7B of revenue in fiscal 2026, up 0.4% on the year before. Over five years, revenue changed +11.6% a year on average.
- Its operating margin was 35.4%, down 1.1 pts: of every 100 in sales, about 35 is left after running the business.
- Copart made $1.5B of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 15.9% a year.
- Free cash flow was $1.3B in fiscal 2026, 27.2% of revenue.
- Copart returned $1.6B to shareholders in fiscal 2026, 129% of free cash flow. The diluted share count fell 2.1%.
- Copart has $1.9B more cash than debt.
Market cap
$27.9B
P/E
—
Revenue
$4.7B
Net income
$1.5B
Free cash flow
$1.3B
Operating margin
35.4%
Copart in 30 seconds · fiscal 2026
Are sales growing?
+0.4%
Only a little. Sales grew 0.4% last year.
Does it make a profit?
31.8%
Yes. It keeps 31.8% of every sale as profit.
Does profit turn into cash?
27.2%
Yes. 27.2% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
What Copart does
No business description yet.
- Fiscal year ends
- July 31, 2026
- Latest annual report
- 10-K · Sep 29, 2026
- Legal name
- COPART, INC.
- CIK
- 0000900075
Copart · CPRT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $3.5B | $3.9B | $4.2B | $4.6B | $4.7B |
| Revenue growth | 30.0% | 10.5% | 9.5% | 9.7% | 0.4% |
| Operating margin | 39.3% | 38.4% | 37.1% | 36.5% | 35.4% |
| Net income | $1.1B | $1.2B | $1.4B | $1.6B | $1.5B |
| Net margin | 31.1% | 32.0% | 32.2% | 33.4% | 31.8% |
| Diluted EPS | $1.13 | $1.28 | $1.40 | $1.59 | $1.55 |
| Cash | |||||
| Cash from operations | $1.2B | $1.4B | $1.5B | $1.8B | $1.6B |
| Capital expenditure | $337M | $517M | $511M | $569M | $337M |
| Free cash flow | $839M | $848M | $962M | $1.2B | $1.3B |
| FCF margin | 24.0% | 21.9% | 22.7% | 26.5% | 27.2% |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $1.6B |
| Share count change | 0.4% | 0.2% | 0.8% | 0.3% | −2.1% |
| Debt and strength | |||||
| Cash and short-term investments | $1.4B | $957M | $1.5B | $2.8B | $1.9B |
| Debt incl. finance leases | $0.0M | $11.0M | $0.0M | $2.7M | $2.7M |
| Shareholders' equity | $4.6B | $6.0B | $7.5B | $9.2B | $9.1B |
| Net debt / EBITDA | −0.9x | −0.6x | −0.9x | −1.5x | −1.0x |
| Current ratio | 5.0x | 6.6x | 7.0x | 8.4x | 7.9x |
| Interest coverage | 74.2x | 568.7x | 502.7x | 840.4x | 885.6x |
| Returns and quality | |||||
| Return on capital | 36.5% | 28.6% | 22.6% | 22.3% | 19.6% |
| Return on equity | 26.7% | 23.3% | 20.2% | 18.6% | 16.2% |
| Piotroski F-score | 5 | 4 | 5 | 4 | 4 |
| Altman Z'' | 13.5 | 15.1 | 15.7 | 18.0 | 17.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$9.4M
4 insiders
Of sales under plans
29%
$2.7M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Copart · CPRT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Copart CPRT | $27.9B | 0.4% | 35.4% | 27.2% | 19.6% | — | 4 |
| RB Global RBA | $15.8B | 7.2% | 15.5% | 15.7% | 7.6% | 36.5x | 6 |
| Science Applications Intl SAIC | $6.4B | −2.9% | 7.2% | 8.0% | 12.8% | 17.3x | 7 |
| KBR KBR | $5.1B | 1.0% | 10.0% | 6.6% | 15.8% | 12.0x | 7 |
| CACI International CACI | $14.8B | 10.9% | 9.6% | 8.2% | 8.8% | 27.3x | 5 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $29.15 a share, the company is worth $27.9B.
Copart grew sales faster than 1 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0000900075). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.